Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Inotiv (NOTV) Gains from Sales and Divestitures (2021 - 2022)

Inotiv filings provide 2 years of Gains from Sales and Divestitures readings, the most recent being $121000.0 for Q3 2022.

On a quarterly basis, Gains from Sales and Divestitures rose 505.0% to $121000.0 in Q3 2022 year-over-year; TTM through Sep 2022 was $121000.0, a 505.0% increase, with the full-year FY2022 number at $121000.0, up 505.0% from a year prior.
Gains from Sales and Divestitures hit $121000.0 in Q3 2022 for Inotiv, up from $20000.0 in the prior quarter.
In the past five years, Gains from Sales and Divestitures ranged from a high of $121000.0 in Q3 2022 to a low of $10.0 in Q1 2021.